Body Shortcuts

Investors

A global pioneer in the development of new drugs

SK biopharmaceuticals shareholder: SK Inc. 50.1%, Others 49.9%

※ As of the end of March 2026 (78,313,250 shares of common stock)

Go to page top
Close Global